Today: 4 April 2026
Subscribe
Browse Category

Stock Market 30 October 2025

Critical Metals (CRML) Stock Skyrockets on Rare-Earth Boom – What’s Next?

Critical Metals (CRML) Stock Skyrockets on Rare-Earth Boom – What’s Next?

Critical Metals Corp (NASDAQ: CRML) jumped 16.8% to $13.54 on Oct. 30, rebounding from mid-October lows after reports the U.S. may take an 8% stake to secure Greenland’s Tanbreez rare-earth project. Shares had surged to $21.45 before plunging over 65% on profit-taking and trade news. CRML also closed a $35M PIPE and signed 10-year supply deals. Analysts remain cautious, citing high volatility and speculative valuation.
30 October 2025
·
Navan’s $6.5B IPO Set for Takeoff – TravelTech Unicorn Aims High, But Will It Deliver?

Navan’s IPO Flop? TravelTech Stock Sinks 12% on Nasdaq Debut

Navan priced its IPO at $25 per share on October 30, 2025, raising about $923 million and valuing the company near $6.2 billion. Shares opened at $22, dropping roughly 12% below the IPO price and trading near $21.14 by midday. The company remains unprofitable, reporting a $38.6 million net loss last quarter. Proceeds will be used to pay down $657 million in debt.
30 October 2025
··
Vivakor (VIVK) Stock Skyrockets on Oil Deal and Trading Debut – Will the Rally Last?

Vivakor (VIVK) Stock Skyrockets on Oil Deal and Trading Debut – Will the Rally Last?

Vivakor shares surged nearly 20% to $0.32 intraday on October 30, 2025, after announcing a $24 million Permian Basin crude oil deal and securing a $40 million credit facility. The Dallas firm also raised $3.5 million in new equity and saw its lender convert $1.45 million of debt into shares, diluting existing holders. VIVK trades below Nasdaq’s $1 minimum and posted a $22 million loss in 2024.
30 October 2025
··
Cardinal Health (NYSE: CAH) Stock Soars to Record High on Blowout Earnings and Raised Outlook

Cardinal Health (NYSE: CAH) Stock Soars to Record High on Blowout Earnings and Raised Outlook

Cardinal Health shares jumped 13% to record highs near $185 after fiscal Q1 2026 results beat estimates, with adjusted EPS at $2.55 and revenue at $64.0 billion. The company raised its full-year outlook and announced a $375 million buyback. All five segments grew profits, marking an eighth straight earnings beat. Cardinal plans to close the Solaris Health acquisition by early November.
30 October 2025
··
Apellis’ $458M Shocker: FDA Win, Analyst Buzz & 20% Stock Whiplash

Apellis’ $458M Shocker: FDA Win, Analyst Buzz & 20% Stock Whiplash

Apellis Pharmaceuticals reported Q3 2025 revenue of $458.6 million and a $215.7 million net profit, but its stock fell about 21% after management warned of future losses. Syfovre sales in the U.S. were flat at $150.9 million, with modest injection growth and ongoing debate over its benefits. Empaveli gained FDA approval for rare kidney diseases in July. Analyst ratings and price targets remain divided.
30 October 2025
·
Cleveland-Cliffs’ Rollercoaster: CLF Stock Soars on Rare-Earth Hype, Plunges on Share Sale – What’s Next?

Cleveland-Cliffs’ Rollercoaster: CLF Stock Soars on Rare-Earth Hype, Plunges on Share Sale – What’s Next?

Cleveland-Cliffs shares fell about 12% to the low-$12 range on Oct. 30, 2025, after announcing a 75 million share offering to raise $964 million, sparking dilution concerns. The drop followed a surge to a 52-week high above $16 on strong Q3 results and rare-earth minerals news. Q3 revenue rose 3.6% to $4.73 billion, with an adjusted net loss of $0.45 per share. Wall Street’s consensus price target remains below recent trading levels.
30 October 2025
·
C.H. Robinson Stock Skyrockets 20% to Record High on AI-Fueled Profit Beat and Raised Outlook

C.H. Robinson Stock Skyrockets 20% to Record High on AI-Fueled Profit Beat and Raised Outlook

C.H. Robinson shares jumped over 20% to a record high after third-quarter earnings beat forecasts, with adjusted EPS at $1.40 versus $1.30 expected. Revenue dropped 10.9%, but profit rose on cost cuts and AI gains. Management raised its 2026 operating income target by $50 million and approved a $2 billion buyback. Analysts lifted price targets, citing operational changes and tech investments.
30 October 2025
···
ServiceNow (NOW) Surges on Blowout Q3 Earnings and 5-for-1 Stock Split Amid AI Boom

ServiceNow (NOW) Surges on Blowout Q3 Earnings and 5-for-1 Stock Split Amid AI Boom

ServiceNow shares jumped nearly 4% to around $950 by midday Oct. 30 after Q3 results beat forecasts, with subscription revenue up 21.5% to $3.30 billion and adjusted EPS at $4.82. The company announced a 5-for-1 stock split pending December approval and raised its full-year outlook. Wall Street remains bullish, with most analysts rating the stock a buy and price targets up to $1,300.
30 October 2025
···
eBay Stock Soars on Earnings Beat, Stumbles on Weak Holiday Outlook

eBay Stock Soars on Earnings Beat, Stumbles on Weak Holiday Outlook

eBay shares surged to a 52-week high above $101 after Q3 2025 earnings beat estimates, with revenue up 9% to $2.82 billion and EPS at $1.36. The stock dropped 7–9% in after-hours trading on Oct. 29 after executives issued a weaker-than-expected holiday profit forecast, citing macro pressures and new tariffs. Year-to-date, eBay is up about 60%. Analyst targets remain split, with the average in the low $90s.
30 October 2025
··
Salesforce Stock Soars After Dreamforce AI Bombshell – What Investors Need to Know (Oct. 21, 2025)

Salesforce (CRM) Stock Rockets After $60B Dreamforce AI Bombshell – Can the Rally Last?

Salesforce shares traded near $258.65 on Oct. 30, 2025, down about 27% from early-year highs and underperforming the S&P 500. Q2 revenue reached $10.24 billion, beating estimates, but cautious Q3 guidance triggered a 5–8% sell-off in September. CEO Marc Benioff’s AI roadmap and $60 billion 2030 target briefly lifted the stock at Dreamforce. Analyst price targets range widely, with consensus at Moderate Buy.
30 October 2025
··
IBM Stock Soars on AI, Quantum, and Cloud Hype – Is the Rally Sustainable?

AI & Quantum Sparks a Big Blue Comeback – IBM Stock Rallies (But Will it Last?)

IBM shares closed near $308 on Oct. 29, 2025, up about 30% year-to-date, after multi-year highs driven by AI and quantum advances. Q3 earnings beat estimates, with revenue at $16.33 billion and adjusted EPS of $2.65; IBM raised full-year guidance. Cloud and Red Hat growth slowed, prompting a 5% after-hours drop on Oct. 22. IBM trades at a forward P/E in the mid-20s and yields a 2.3% dividend.
30 October 2025
·······
SAP Stock Skyrockets on Cloud Boom – Analysts Eye New Highs?

SAP Stock Soars on Cloud Surge — Can the Rally Continue?

SAP shares traded near $262 on Oct. 30, 2025, roughly flat for the year after a 75% surge over 12 months. Q3 revenue rose 7% to €9.08 billion, with cloud sales up 22% and backlog at a record €18.84 billion. SAP raised its 2025 profit outlook but expects cloud revenue at the low end of guidance. The stock swung sharply after earnings, closing between $259 and $279 during the week.
30 October 2025
··
Quantum Breakthrough or Bubble? Rigetti Stock Rockets 5,000% in 2025

Quantum Breakthrough or Bubble? Rigetti Stock Rockets 5,000% in 2025

Rigetti Computing shares soared nearly 5,000% in 2025, peaking at $56 in mid-October before dropping to the high $30s. The company won a $5.8 million U.S. Air Force contract and launched a 36-qubit processor, but Q2 revenue was just $1.8 million against a $39.7 million net loss. Market cap reached $12–17 billion, drawing analyst warnings of overvaluation. U.S. policy speculation fueled further volatility.
30 October 2025
··
Pfizer Stock Soars: Trump’s Drug-Price Deal and $7B Weight-Loss Bet Spark Rally

Pfizer Stock Soars: Trump’s Drug-Price Deal and $7B Weight-Loss Bet Spark Rally

Pfizer shares traded near $24.20 on Oct. 30, 2025, flat for the week and close to the low end of their 52-week range. The stock surged 15% in late September after Pfizer agreed to cut Medicaid drug prices and announced a $7.3 billion deal to acquire obesity-drug maker Metsera. Rival Novo Nordisk countered with a higher bid for Metsera. Q3 earnings are due Nov. 4, with analysts expecting a sharp year-over-year decline.
30 October 2025
··
SoFi Stock Rockets 230% in 2025 on Record Q3 and Fintech Boom

SoFi Stock Rockets 230% in 2025 on Record Q3 and Fintech Boom

SoFi shares surged 230% year-over-year, closing at $31.66 after Q3 earnings on Oct. 28 before slipping to around $29.90 by Oct. 30. The company beat Q3 forecasts with $950 million in adjusted net revenue and raised its 2025 guidance. Analysts remain split, with targets ranging from $18 to $36. Cathie Wood’s ARK Invest doubled its stake last quarter, while institutional ownership stands near 48%.
30 October 2025
···
Nokia (NOK) Stock Soars on $1B Nvidia Deal & Massive 5G Contract Wins

Nokia (NOK) Stock Soars on $1B Nvidia Deal & Massive 5G Contract Wins

Nokia shares surged 20–25% in late October 2025, reaching multi-year highs after strong Q3 results and news of a $1 billion investment from NVIDIA for a 2.9% stake. The companies announced a strategic AI and 6G networking partnership. Nokia’s Q3 sales rose 12% to €4.83 billion, beating forecasts, with operating profit at €435 million. Major 5G and network contracts were secured with Vodafone, Rakuten, Elisa, and E.ON.
30 October 2025
··
Ford (F) Stock Surges on Earnings – Rally Faces EV & Recall Challenges

Ford (F) Stock Surges on Earnings – Rally Faces EV & Recall Challenges

Ford shares jumped 10% after Q3 earnings beat forecasts, closing near a one-year high at around $13. Revenue hit $50.5 billion, up 9% year-over-year, but the company cut 2025 profit guidance by up to $2 billion due to a supplier fire. Ford’s EV unit continues to post losses, and the automaker faces record recalls and higher labor costs. The dividend resumed at $0.15 per share, with most analysts rating the stock a “Hold.”
30 October 2025
···
Explosive Rally and Volatility: Bitcoin’s Surge Propels Bitfarms Stock

Explosive Rally and Volatility: Bitcoin’s Surge Propels Bitfarms Stock

Bitfarms Ltd. (NASDAQ: BITF) stock surged from about $1 in January to over $6 in mid-October 2025, before dropping nearly 40% and rebounding to around $4.90 by Oct. 27. The company raised $588 million in convertible notes to fund a new Pennsylvania data center and expand into AI infrastructure. Bitfarms also announced a CFO transition and moved its headquarters to the U.S. Analyst targets remain mixed amid ongoing losses.
30 October 2025
···
1 … 1,265 1,266 1,267 1,268 1,269 … 1,371

Stock Market Today

  • Transurban Group (ASX:TCL) Shares Down 2.26% in 2024: Key Metrics and Financial Health Reviewed
    April 4, 2026, 6:23 AM EDT. Transurban Group (ASX:TCL) shares have declined by 2.26% since the start of 2024. The company operates 22 urban toll roads across Australia, Canada, and the U.S., notably CityLink in Melbourne and Hills M2 in Sydney. Key financial indicators include annual revenue of AUD 4.12 billion with a 3-year CAGR of 12.6%, a gross margin of 57%, and a reported profit drop to AUD 326 million from AUD 3.3 billion three years ago, reflecting a negative profit CAGR of 53.8%. Financial health shows a substantial net debt of AUD 18 billion and a high debt-to-equity ratio of 175.1%, implying increased leverage risk despite stable revenues. Investors should watch for return on equity and ongoing project developments impacting toll revenue streams.
Go toTop